Small Entity Designation. If Syllable, its Subsidiaries, any Sublicensee and/or any holder of an option to obtain a Sublicense does not qualify, or at any point during the Term ceases to qualify, as an entity entitled to pay lesser fees as provided by the USPTO (i.e., a “small entity”) or the patent office of any other country, Syllable shall so notify Harvard immediately, in order to enable Harvard to comply with regulations regarding payment of fees with respect to Patent Rights.
Appears in 2 contracts
Sources: License Agreement (Neumora Therapeutics, Inc.), License Agreement (Neumora Therapeutics, Inc.)